BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 24661651)

  • 21. A single-institution review of accelerated partial breast irradiation in patients considered "cautionary" by the American Society for Radiation Oncology.
    Stull TS; Catherine Goodwin M; Gracely EJ; Chernick MR; Carella RJ; Frazier TG; Barrio AV
    Ann Surg Oncol; 2012 Feb; 19(2):553-9. PubMed ID: 21769461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast-conserving surgery with or without radiotherapy in women with ductal carcinoma in situ: a meta-analysis of randomized trials.
    Viani GA; Stefano EJ; Afonso SL; De Fendi LI; Soares FV; Leon PG; GuimarĂ£es FS
    Radiat Oncol; 2007 Aug; 2():28. PubMed ID: 17683529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic Significance of Clinicopathologic Features in Patients With Breast Ductal Carcinoma-in-Situ Who Received Breast-Conserving Surgery.
    Kuo SH; Lo C; Chen YH; Lien HC; Kuo WH; Wang MY; Lee YH; Huang CS
    Clin Breast Cancer; 2018 Dec; 18(6):441-450.e2. PubMed ID: 29709458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of Radiotherapy Boost for Ductal Carcinoma In Situ With Local Control After Whole-Breast Radiotherapy.
    Moran MS; Zhao Y; Ma S; Kirova Y; Fourquet A; Chen P; Hoffman K; Hunt K; Wong J; Halasz LM; Freedman G; Prosnitz R; Yassa M; Nguyen DHA; Hijal T; Haffty BG; Wai ES; Truong PT
    JAMA Oncol; 2017 Aug; 3(8):1060-1068. PubMed ID: 28358936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation of clinical and pathologic features with outcome in patients with ductal carcinoma in situ of the breast treated with breast-conserving surgery and radiotherapy.
    Rodrigues N; Carter D; Dillon D; Parisot N; Choi DH; Haffty BG
    Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1331-5. PubMed ID: 12459354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study.
    Benitez PR; Streeter O; Vicini F; Mehta V; Quiet C; Kuske R; Hayes MK; Arthur D; Kuerer H; Freedman G; Keisch M; Dipetrillo T; Khan D; Hudes R
    Am J Surg; 2006 Oct; 192(4):427-33. PubMed ID: 16978943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accelerated partial breast irradiation for pure ductal carcinoma in situ.
    Park SS; Grills IS; Chen PY; Kestin LL; Ghilezan MI; Wallace M; Martinez AM; Vicini FA
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):403-8. PubMed ID: 20800374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Omitting radiation therapy after lumpectomy for pure DCIS does not reduce the risk of salvage mastectomy.
    Rakovitch E; Nofech-Mozes S; Hanna W; Sutradhar R; Gu S; Fong C; Tuck A; Youngson B; Miller N; Done SJ; Chang MC; Sengupta S; Elavathil L; Jani PA; Bonin M; Lalani N; Paszat L
    Breast; 2018 Feb; 37():181-186. PubMed ID: 28781102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic Factors for Local Control in Breast Cancer After Long-term Follow-up in the EORTC Boost vs No Boost Trial: A Randomized Clinical Trial.
    Vrieling C; van Werkhoven E; Maingon P; Poortmans P; Weltens C; Fourquet A; Schinagl D; Oei B; Rodenhuis CC; Horiot JC; Struikmans H; Van Limbergen E; Kirova Y; Elkhuizen P; Bongartz R; Miralbell R; Morgan DA; Dubois JB; Remouchamps V; Mirimanoff RO; Hart G; Collette S; Collette L; Bartelink H;
    JAMA Oncol; 2017 Jan; 3(1):42-48. PubMed ID: 27607734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ductal carcinoma in situ of the breast with close or focally involved margins following breast-conserving surgery: treatment with reexcision or radiotherapy with increased dosage.
    Monteau A; Sigal-Zafrani B; Kirova YM; Fourchotte V; Bollet MA; Vincent-Salomon A; Asselain B; Salmon RJ; Fourquet A
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1021-8. PubMed ID: 19386441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concurrent lobular neoplasia increases the risk of ipsilateral breast cancer recurrence in patients with ductal carcinoma in situ treated with breast-conserving therapy.
    Rudloff U; Brogi E; Brockway JP; Goldberg JI; Cranor M; Wynveen CA; Nehhozina T; Reiner AS; Patil S; Van Zee KJ
    Cancer; 2009 Mar; 115(6):1203-14. PubMed ID: 19170233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors predicting in-breast tumor recurrence after breast-conserving surgery.
    Mechera R; Viehl CT; Oertli D
    Breast Cancer Res Treat; 2009 Jul; 116(1):171-7. PubMed ID: 18815880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcome after ipsilateral breast tumor recurrence in patients with early-stage breast cancer treated with accelerated partial breast irradiation.
    Shah C; Wilkinson JB; Jawad M; Wobb J; Berry S; Mitchell C; Wallace M; Vicini FA
    Clin Breast Cancer; 2012 Dec; 12(6):392-7. PubMed ID: 23063380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Women with Low-Risk DCIS Eligible for the LORIS Trial After Complete Surgical Excision: How Low Is Their Risk After Standard Therapy?
    Pilewskie M; Olcese C; Patil S; Van Zee KJ
    Ann Surg Oncol; 2016 Dec; 23(13):4253-4261. PubMed ID: 27766556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The frequency of ipsilateral second tumors after breast-conserving surgery for DCIS: a population based analysis.
    Warren JL; Weaver DL; Bocklage T; Key CR; Platz CE; Cronin KA; Ballard-Barbash R; Willey SC; Harlan LC
    Cancer; 2005 Nov; 104(9):1840-8. PubMed ID: 16136599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study.
    Reitsamer R; Peintinger F; Kopp M; Menzel C; Kogelnik HD; Sedlmayer F
    Strahlenther Onkol; 2004 Jan; 180(1):38-44. PubMed ID: 14704843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of boost radiotherapy in patients with ductal carcinoma in situ breast cancer: a multicenter, retrospective study in Korea (KROG 11-04).
    Kim JH; Choi DH; Park W; Ahn SD; Kim SS; Ha SW; Kim K; Kim YB; Yea JW; Kang MK; Shin KH; Kim DW; Lee JH; Suh CO
    Breast Cancer Res Treat; 2014 Jul; 146(2):341-5. PubMed ID: 24939061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Local recurrence after conservative surgery and radiation therapy for ductal carcinoma in situ: Possible importance of family history.
    Hiramatsu H; Bornstein BA; Recht A; Schnitt SJ; Baum JK; Connolly JL; Duda RB; Guidi AJ; Kaelin CM; Silver EB; Harris JR
    Cancer J Sci Am; 1995; 1(1):55-61. PubMed ID: 9166455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
    Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
    Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ductal carcinoma in situ treated with breast-conserving surgery and radiotherapy: a comparison with ECOG study 5194.
    Motwani SB; Goyal S; Moran MS; Chhabra A; Haffty BG
    Cancer; 2011 Mar; 117(6):1156-62. PubMed ID: 21381008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.